Variation in anticoagulant composition regulates differential effects of prothrombin complex concentrates on thrombin generation

Journal of Thrombosis and Haemostasis

Volumn 7, Issue 12, 2009, Pages 2154-2156

  Gilmore, R ^a   Harmon, S ^a   Keane, G ^a   Gannon, C ^a   O'Donnell, J S ^a  

^a ST JAMES S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR; PROTHROMBIN COMPLEX CONCENTRATES; THROMBIN; WARFARIN;

BIOSYNTHESIS; DRUG EFFECT; HUMAN; LETTER;

ANTICOAGULANTS; BLOOD COAGULATION FACTORS; HUMANS; THROMBIN; WARFARIN;

EID: 77449152533     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2009.03609.x     Document Type: Letter

References (16)

1. Samama CM. Prothrombin complex concentrates: a brief review. Eur J Anaesthesiol 2008; 10: 784-9.
2. Hellstern P. Production and composition of prothrombin complex concentrates: correlation between composition and therapeutic efficiency. Thromb Res 1999; 95 (Suppl. 1): S7-12.
3. Baglin TP, Keeling DM, Watson HG. Guidelines on oral anticoagulation (warfarin): third edition - 2005 update. Br J Haematol 2006; 132: 277-85.
4. Baker RI, Coughlin PB, Gallus AS, Harper PL, Salem HH, Wood EM. Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis. Med J Aust 2004; 181: 492-7.
5. Schulman S, Beyth RJ, Kearon C, Levine MN. Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133 (Suppl.): 257S-98S.
6. Lusher JM. Thrombogenicity associated with factor IX complex concentrates. Semin Hematol 1991; 28 (Suppl. 6): 3-5.
7. Lankiewicz MW, Hays J, Friedman KD, Tinkoff G, Blatt PM. Urgent reversal of warfarin with prothrombin complex concentrate. J Thromb Haemost 2006; 5: 967-70.
8. Dargaud Y, Smurs-Clavel H, Marin S, Bordet JC, Poplavsky JL, Negrier C. Comparison of the capacities of two prothrombin complex concentrates to restore thrombin generation in plasma from orally anticoagulated patients: an in vitro study. J Thromb Haemost 2008; 6: 962-8.
9. Gatt A, Van Veen JJ, Woolley AM, Kitchen S, Cooper P, Makris M. Thrombin generation assays are superior to traditional tests in assessing anticoagulation reversal in vitro. Thromb Haemost 2008; 100: 350-5.
10. Hemker HC, Beguin S. Thrombin generation in plasma: its assessment via the endogenous thrombin potential. Thromb Haemost 1995; 74: 134-8.
11. Preston RJ, Tran S, Johnson JA, Ainle FN, Harmon S, White B, Smith OP, O'Donnell JS. Platelet factor 4 impairs the anticoagulant activity of activated protein C. J Biol Chem 2009; 284: 5869-75.
12. Gatt A, Van Veen JJ, Bowyer A, Woolley AM, Cooper P, Kitchen S, Makris M. Wide variation in thrombin generation in patients with atrial fibrillation and therapeutic International Normalized Ratio is not due to inflammation. Br J Haematol 2008; 142: 946-52.
13. Leissinger CA, Blatt PM, Hoots WK, Ewenstein B. Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature. Am J Hematol 2008; 83: 137-43.
14. Aledort LM. Factor IX and thrombosis. Scand J Haematol 1977; 30: 40-2.
15. Blauhut B. Indications for prothrombin complex concentrates in massive transfusions. Thromb Res 1999; 95 (Suppl. 1): S63-9.
16. Bohrer H. Prothrombin complex concentrate substitution during liver transplantation. Thromb Res 1999; 95 (Suppl. 1): S71-4.